These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21149430)

  • 21. RENAL, HEPATIC AND IMMUNE FUNCTION INDICES IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY.
    Kononets O; Karaiev T; Tkachenko O; Lichman L
    Georgian Med News; 2020 Dec; (309):64-71. PubMed ID: 33526732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress.
    Grosso S; Perrone S; Longini M; Bruno C; Minetti C; Gazzolo D; Balestri P; Buonocore G
    Brain Dev; 2008 Jun; 30(6):391-5. PubMed ID: 18180123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to american academy of pediatrics recommendations for cardiac care among female carriers of duchenne and becker muscular dystrophy.
    Bobo JK; Kenneson A; Kolor K; Brown MA
    Pediatrics; 2009 Mar; 123(3):e471-5. PubMed ID: 19254982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Liver function tests" are not always tests of liver function.
    Korones DN; Brown MR; Palis J
    Am J Hematol; 2001 Jan; 66(1):46-8. PubMed ID: 11426492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis between Duchenne and Becker types muscular dystrophy.
    Ishpekova B; Milanov I; Christova LG; Alexandrov AS
    Electromyogr Clin Neurophysiol; 1999; 39(5):315-8. PubMed ID: 10422002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of hepatic transaminases to recognize abuse in children.
    Lindberg D; Makoroff K; Harper N; Laskey A; Bechtel K; Deye K; Shapiro R;
    Pediatrics; 2009 Aug; 124(2):509-16. PubMed ID: 19620197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early clinical and histopathological manifestations in 14 boys showing elevated serum creatine-phosphokinase levels in their first year].
    Guibaud P; Carrier HN; Plauchu H; Lauras B; Jolivet MJ; Robert JM
    J Genet Hum; 1981 Mar; 29(1):71-84. PubMed ID: 7334343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preliminary study of serum enzymology in Duchenne muscular dystrophy].
    Wu KM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):342-5. PubMed ID: 3836825
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of electrocardiogram abnormalities in young patients with duchenne muscular dystrophy.
    Takami Y; Takeshima Y; Awano H; Okizuka Y; Yagi M; Matsuo M
    Pediatr Neurol; 2008 Dec; 39(6):399-403. PubMed ID: 19027585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy.
    Kenneson A; Bobo JK
    Health Soc Care Community; 2010 Sep; 18(5):520-8. PubMed ID: 20561071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enzymology of skeletal muscle disorders.
    Lott JA; Landesman PW
    Crit Rev Clin Lab Sci; 1984; 20(2):153-90. PubMed ID: 6373145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of 18 cases of Becker muscular dystrophy].
    Bernal Sánchez-Arjona M; Sanz-Fernández G; Travado-Soria P; Fernández-García R; Chinchón-Lara I; Antiñolo G; Bautista-Lorite J
    Rev Neurol; 2004 Jun 1-15; 38(11):1090-2. PubMed ID: 15202090
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience].
    Falsaperla R; Romeo G; Sciacca P; Di Giorgio A; Mattia CL; Distefano G
    Pediatr Med Chir; 2001; 23(1):57-60. PubMed ID: 11486424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated aminotransferase activity as an indication of muscular dystrophy: case reports and review of the literature.
    Zamora S; Adams C; Butzner JD; Machida H; Scott RB
    Can J Gastroenterol; 1996 Oct; 10(6):389-93. PubMed ID: 9193775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric FAST and elevated liver transaminases: An effective screening tool in blunt abdominal trauma.
    Sola JE; Cheung MC; Yang R; Koslow S; Lanuti E; Seaver C; Neville HL; Schulman CI
    J Surg Res; 2009 Nov; 157(1):103-7. PubMed ID: 19592033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.